A novel series of hedgehog signaling pathway inhibitors has been designed based on the 4-(2-pyrimidinylamino) benzamides scaffold. The synthesis and SAR of these compounds are described. Optimization leads to the identification of compound 3c, a potent and orally available agent with improved physicochemical and pharmacokinetic properties.
Keywords: Hedgehog signaling pathway; Inhibitors; Pharmacokinetic properties; SAR.
Copyright © 2014 Elsevier Ltd. All rights reserved.